| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 118558-99-9 | methyl 2-((benzylamino)methyl)-3-hydroxybutanoate
| |
C13H19NO3 | 237.29 |
| 1431948-81-0 | methyl 2,6-difluoro-4-vinylbenzoate
| 密度：1.225±0.06 g/cm3(Predicted)
沸点：264.2±40.0℃(Predicted)
|
C10H8F2O2 | 198.17 |
| 1052647-30-9 | methyl 2,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
| |
C16H23BO4 | 290.16 |
| 1924343-23-6 | Methyl 1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
| |
C9H9N3O2 | 191.190 |
| 112375-56-1 | METHYL (E)-6-METHYLHEPT-4-ENOATE
| |
C9H16O2 | 156.22 |
| 683246-09-5 | methyl (E)-4-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)benzoate
| |
C15H18O4 | 262.3 |
| 118417-75-7 | methyl (2R)-3-chloro-2-methylpropionate
| |
C5H9ClO2 | 136.58 |
| 138093-73-9 | Methyl (2R)-3-aMino-2- {[(benzyloxy)carbonyl]aMino}propanoate hydrochloride
Methyl (2R)-3-aMino-2- [(benzyloxy)carbonyl]aMinopropanoate hydrochloride | |
C13H18N2O4 | 266.29 |
| 1446016-54-1 | Methanesulfonic acid, 1,1,1-trifluoro-, 3-nitro-5-(trifluoromethyl)phenyl ester
| |
C8H3F6NO5S | 339.1685392 |
| 1049637-73-1 | methanesulfonic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl) ester
| |
C8H15NO3S | 205.27 |
| 1049637-71-9 | methanesulfonic acid (R)-(1-aza-bicyclo[2.2.2]oct-3-yl) ester
| |
C8H15NO3S | 205.27 |
| 2562346-14-7 | Mesdopetam L-tartrate salt
| |
| |
| 894096-02-7 | Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc
| |
C38H40N2O14 | 748.73 |
| 104676-09-7 | 4-((2,5-Dioxo-2,5-Dihydro-1H-Pyrrol-1-Yl)Methyl)Cyclohexane-1-Carboxamide | |
C12H16N2O3 | 236.27 |
| 1639351-92-0 | Mc-Val-Cit-PAB-Cl
| |
C28H39ClN6O6 | 591.1 |
| 1375089-56-7 | MC-DM1
(14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl)-N-methyl | |
C42H55ClN4O12 | 843.36 |
| 359436-59-2 | Mal-C2-cyclohexylcarboxyl-hydrazide (TFA)
| |
C14H18F3N3O5 | 365.31 |
| 1263044-88-7 | Mal-Ph-CONH-PEG4-NHSester
| |
C26H31N3O11 | 561.54 |
| 518044-35-4 | Mal-PEG3-Boc
| |
C17H27NO7 | 357.4 |
| 2128735-24-8 | Mal-NH-ethyl-SS-propionicacid
| |
C12H16N2O5S2 | 332.40 |
| 2169232-81-7 | Magrolimab单抗
Magrolimab | |
| |
| 678150-56-6 | m-PEG7-4-nitrophenyl carbonate
| |
C20H31NO11 | 461.46 |
| 1920109-55-2 | m-PEG4-CH2-methyl ester
| |
C12H24O6 | 264.32 |
| 874208-84-1 | m-PEG4-CH2-acid
| |
C11H22O6 | 250.29 |
| 248275-10-7 | m-PEG3-Aminooxy
| |
C7H17NO4 | 179.21 |
| 173414-89-6 | m-C-tri(CH2-PEG1-NHSester)
| |
C26H33N3O15 | 627.55 |
| 1307245-87-9 | LY-2940094 L-2,3-二羟基丁二酸盐
LY-2940094 tartrate | |
C26H29ClF2N4O8S | 631.05 |
| 2676177-63-0 | LUNA18
(5S,8S,11S,15S,18S,23aS,29S,35S,37aS)-8-((S)-sec-Butyl)-18-cyclopentyl-29-(3,5-difluoro-4-(trifluoromethyl)phenethyl)-36-ethyl-11-isobutyl-N,N,5,6,12,16,19,33-octamethyl-35-(4-methylbenzyl)-4,7,10,13,17,20,23,28,31,34,37-undecaoxotetratriacontahydro-2H,4H | |
C73H105F5N12O12 | 1437.68 |
| 181112-35-6 | Loperamide Oxide Hydrate
Loperamide Related Compound F | |
C29H35ClN2O4 | 511.06 |
| 1416951-85-3 | LKS-01
N-[(3-Methyl-1H-inden-2-yl)carbonyl]-D-alanyl-N-[(1S)-2-[(2R)-2-methyl-
2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-N6-[(phenylmethoxy)carbonyl]-L-lysinamide | |
C40H46N4O7 | 694.82 |
| 1000676-41-4 | Lirilumab单抗
Lirilumab | |
| |
| 851199-60-5 | Linaclotide acetate
((3S,6R,15R,20R,23S,26R,29R,32R,37R,40S,45aS)-32-Amino-40-(2-amino-2-oxoethyl)-26-(2-carboxyethyl)-23-(4-hydroxybenzyl)-9-((R)-1-hydroxyethyl)-3-methyl-1,4,7,10,13,22,25,28,31,38,41,47-dodecaoxotetracontahydro-19H-37,20-(epiminomethano)-6,29-(methanodithi | |
C61H83N15O23S6 | 1586.78 |
| 1322627-61-1 | Ligelizumab单抗
Ligelizumab | |
| |
| 2489242-23-9 | Lenalidomide-propargyl-C2-NH2(hydrochloride)
| |
C18H20ClN3O3 | 361.82 |
| 388619-64-5 | Lacosamide N-Methyl Impurity
N-Methyl rac-Lacosamide | |
C14H20N2O3 | 264.32 |
| 140834-91-9 | L-苯丙氨酸,N-[N-[(1,1-二甲基乙氧基)羰基]-D-亮氨酰]-苯甲酯
N-[N-[(1,1-Dimethylethoxy)Carbonyl]-D-Leucyl]-Phenylmethyl Ester L-Phenylalanine | |
C27H36N2O5 | 468.59 |
| 59681-31-1 | L-脯氨酸-15N
L-Proline-15N | |
C5H9(15N)O2 | 116.12 |
| 1392411-97-0 | L-脯氨酰-L-脯氨酰-L-脯氨酸 三氟乙酸盐
L-Prolyl-L-prolyl-L-proline 2,2,2-trifluoroacetate | |
C17H24F3N3O6 | 423.38 |
| 4070-48-8 | MethylL-valinate | |
C6H13NO2 | 131.17 |
| 5256-76-8 | L-精氨酸 α-酮戊二酸盐(2:1)
α-ketoglutaric acid di-L-arginine salt | |
C5H6O5*2C6H14N4O2 | 494.505 |
| 59587-18-7 | L-精氨酰甘氨酰-L-酪氨酰-L-丝氨酰-L-亮氨酰甘氨酸
L-Arginylglycyl-L-tyrosyl-L-seryl-L-leucylglycine | |
C28H45N9O9 | 651.71 |
| 61380-66-3 | L-樟脑磺酸
L-(+)-camphorsulfonicacid | 熔点：198 ℃
沸点：467.7 ℃ at 760 mmHg
|
C10H16O4S | 232.3 |
| 70592-18-6 | L-丙氨酰-L-脯氨酰甘氨酰-L-缬氨酸甘氨酰-L-缬氨酸
L-Alanyl-L-prolylglycyl-L-valylglycyl-L-valine | |
C22H38N6O7 | 498.57 |
| 1001098-63-0 | L-Proline, 4-[[(4-bromophenyl)sulfonyl]oxy]-, methyl ester, hydrochloride (1:1), (4S)-
| |
C12H15BrClNO5S | 400.67 |
| 2443716-15-0 | L-6-羟基色氨酸三氟乙酸盐
6-Hydroxy-L-tryptophan(TFA) | |
C13H13F3N2O5 | 334.25 |
| 2511244-97-4 | Ivabradine N-Oxide
| |
C27H36N2O6 | 484.58 |
| 1116433-11-4 | Itolizumab单抗
Itolizumab | |
| |
| 625126-88-7 | Isoquinoline, 1,2,3,4-tetrahydro-5-iodo-2-(trifluoroacetyl)-7-(trifluoroMethyl)-
| |
C12H8F6INO | 423.09 |
| 284027-34-5 | Isoquinoline, 1,2,3,4-tetrahydro-2-(trifluoroacetyl)-7-(trifluoroMethyl)-
| 密度：1.425±0.06 g/cm3(Predicted)
沸点：339.8±42.0℃(Predicted)
|
C12H9F6NO | 297.2 |
| 220089-22-5 | Isopropyl 4-acetylbenzoate
| |
C12H14O3 | 206.24 |
